Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.15M | 13.12M | -9.47M | -9.77M | 3.32M |
| Total Other Revenue | 970.40K | 899.80K | 689.10K | 710.70K | 1.68M |
| Total Revenue | 15.12M | 14.02M | -8.78M | -9.06M | 5.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 15.12M | 14.02M | -8.78M | -9.06M | 5.00M |
| SG&A Expenses | 6.41M | 5.94M | 5.17M | 5.33M | 5.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.65M | 13.59M | 15.06M | 15.53M | 17.66M |
| Operating Income | 462.50K | 428.80K | -23.84M | -24.59M | -12.66M |
| Income Before Tax | -3.05M | -2.83M | -24.68M | -25.45M | -11.69M |
| Income Tax Expenses | 3.40K | 3.20K | -22.90K | -23.60K | 77.50K |
| Earnings from Continuing Operations | -3.05M | -2.83M | -24.66M | -25.43M | -11.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.05M | -2.83M | -24.66M | -25.43M | -11.77M |
| EBIT | 462.50K | 428.80K | -23.84M | -24.59M | -12.66M |
| EBITDA | 619.10K | 574.10K | -23.68M | -24.42M | -12.23M |
| EPS Basic | -0.06 | -0.06 | -0.52 | -0.54 | -0.25 |
| Normalized Basic EPS | -0.05 | -0.04 | -0.35 | -0.36 | -0.17 |
| EPS Diluted | -0.06 | -0.06 | -0.52 | -0.54 | -0.25 |
| Normalized Diluted EPS | -0.05 | -0.04 | -0.35 | -0.36 | -0.17 |
| Average Basic Shares Outstanding | 47.42M | 47.42M | 47.41M | 47.41M | 47.12M |
| Average Diluted Shares Outstanding | 47.42M | 47.42M | 47.41M | 47.41M | 47.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |